Hyperphenylalaninemia is the most prevalent amino acid metabolism disorder, resulting from a deficiency of either phenylalanine hydroxylase (PAH) or its cofactor, tetrahydrobiopterin (BH4). Here, PAH is linked to pulmonary arterial hypertension.